Biotechnology, Clinical trial, Oncology, Epidemiology, Vaccination, Immune system

Six Biotechs to Watch in 2021

On Jan 27, 2021
@ErnestoChanona shared
RT @BioBuzzMaryland: Six life science companies to keep an eye on in 2021 and beyond https://t.co/f1Cph2u8Pv https://t.co/toKeVnSJ6A
Open

By investing over $77M, HLB Co., LTD, a global pharmaceutical company focused on developing novel cancer drugs, ITI is well-positioned to accelerate its immuno-oncology platform, in particular glioblastoma multiforme, and rapidly advance other key candidates in our pipeline, including the ...

biobuzz.io
On Jan 27, 2021
@ErnestoChanona shared
RT @BioBuzzMaryland: Six life science companies to keep an eye on in 2021 and beyond https://t.co/f1Cph2u8Pv https://t.co/toKeVnSJ6A
Open

Six Biotechs to Watch in 2021

Six Biotechs to Watch in 2021

By investing over $77M, HLB Co., LTD, a global pharmaceutical company focused on developing novel cancer drugs, ITI is well-positioned to accelerate its immuno-oncology platform, in ...

Get to Know 15 Awesome Biotechs in Paris

Get to Know 15 Awesome Biotechs in Paris

Paris attracts millions of tourists to see some of the world’s most iconic monuments: the Eiffel Tower, the Louvre, the Arc de Triomphe … but it also attracts a lot of biotechs. Here are 15 ...

INOVIO Expands Senior Management Team

INOVIO Expands Senior Management Team

INOVIO Expands Senior Management Team - read this article along with other careers information, tips and advice on BioSpace

Top 10 Biotechs in Lausanne

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. %

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7(TM) in Glioblastoma Multiforme

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7(TM) in Glioblastoma Multiforme

SHANGHAI, GAITHERSBURG, Md. and SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development ...

Five Biotechs to Watch in 2020

Five Biotechs to Watch in 2020

Five Biotechs to Watch in 2020 2019 was a banner year for the biotech industry which is was brimming with innovation and growth, especially within the BioHealth Capital Region (BHCR). ...

In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

From chief scientific officer of Bristol Myers Squibb (back when it still had a hyphen) to running one of the biggest cancer research organizations in the world is a major career shift and ...

Replicate Bioscience and Immunomic Therapeutics Form Collaboration to Combat Infectious Diseases and Cancers

Replicate Bioscience and Immunomic Therapeutics Form Collaboration to Combat Infectious Diseases and Cancers

Replicate Bioscience, Inc. (“Replicate”), a privately-held biopharmaceutical company creating novel treatments to prevent drug resistance in cancers,

Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More

Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More

Clinical trials have historically hewn to a rigid format. A trial is designed, conducted according to that design, and then results are analyzed. Making

Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research

Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research

Former Fred Hutch President and Director Dr. Larry Corey talks about his new role heading operations for the COVID-19 Prevention Network, a collaboration established by Dr. Tony Fauci. ...

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Additionally, Sutro’s partner Merck KGaA, Darmstadt, Germany, will be unveiling preclinical data from the collaboration’s pre-Development Candidate, a first-in-class bispecific ...

Seven Biopharma Trends to Watch in 2021

Seven Biopharma Trends to Watch in 2021

It’s not all COVID-19! Check out gene editing, gene and cell therapy, and other areas.

The new pharma collaborations driving transformative research in oncology

The new pharma collaborations driving transformative research in oncology

With the breadth and complexity of emerging science driving innovation in oncology, collaborations are essential in order that relevant expertise, know-how and capabilities can be combined ...

Fourth large-scale COVID-19 vaccine trial begins in the United States

Fourth large-scale COVID-19 vaccine trial begins in the United States

Trial evaluating investigational Janssen COVID-19 vaccine.

Fourth Large-Scale COVID-19 Vaccine Trial Begins in the United States

Fourth Large-Scale COVID-19 Vaccine Trial Begins in the United States

A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers. The trial is designed to evaluate if the ...

Advancing new tools for infectious diseases

Advancing new tools for infectious diseases

Several infectious diseases cause considerable mortality worldwide each year: Tuberculosis causes ∼1.2 million deaths, diarrheal disease causes ∼1.5 million deaths, and lower respiratory ...

The CipherBio List of Top Founders, Entrepreneurs and CEOs in the Life Science Sector

The CipherBio List of Top Founders, Entrepreneurs and CEOs in the Life Science Sector

Meet the life science entrepreneurs, founders and CEOs that have driven the growth of the top performing biotech companies.

Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico

Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico

PREVENT-19 will assess the efficacy, safety and immunogenicity of NVX-CoV2373 in the prevention of COVID-19 Trial to enroll up to 30,000 volunteers across approximately 115 sites in the ...